載入...
A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record
OBJECTIVE: Recently, the European Medicines Agency reported that strontium ranelate increases myocardial infarction risk in postmenopausal women, 8.5 years after it was registered for use in osteoporosis. Unreported serious adverse events in clinical trials for other pharmaceuticals have been descri...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4187454/ https://ncbi.nlm.nih.gov/pubmed/25293384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-005787 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|